This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Keytruda
  • /
  • Study of Pembrolizumab (MK-3475) Plus Enzalutamide...
Clinical trial

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Read time: 3 mins
Last updated:27th Jul 2019
Identifier: NCT03834493
Register free for full access to medthority.com